<\/div>Pim de Graaf<\/h3>Netherlands<\/span><\/div><\/div><\/div><\/div><\/div><\/div><\/div>[\/vc_column][vc_column width=”1\/3″][\/vc_column][\/vc_row][vc_row row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” css_animation=””][vc_column][vc_separator type=”normal”][\/vc_column][\/vc_row][vc_row row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” css_animation=””][vc_column][vc_column_text]<\/p>\nDescription of Working Group:<\/em><\/h4>\nThe European Retinoblastoma Imaging Collaboration was founded in 2009 and since then this international group of radiologists has met twice a year in Amsterdam with the aim of increasing the quality and diagnostic value of MRI in retinoblastoma through multicenter research.<\/p>\n
<\/p>\n
Objectives of Working Group:\u00a0<\/em><\/h4>\n\n- \n
\n- To harmonize high-quality MR imaging through development of guidelines for retinoblastoma imaging.<\/li>\n
- To improve disease staging by enhancing diagnostic accuracy for pretreatment detection of high-risk features.<\/li>\n
- To identify the influence of genetic driver mutations and other chromosomal abnormalities on the retinoblastoma radiophenotype.<\/li>\n<\/ol>\n<\/li>\n<\/ol>\n
[\/vc_column_text][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner][vc_separator type=”normal”][vc_column_text]<\/p>\n
Guidelines<\/em><\/h4>\nOn behalf of the ERIC and EURbG we propose an updated MR protocol and a standardized reporting system<\/strong> based on the key points essential for managing patients with retinoblastoma by ophthalmologists and pediatric oncologists. Following the guidelines leads to state-of-the-art imaging in \u00a0retinoblastoma and can improve diagnostic yield and understanding of clinically significant imaging features of retinoblastoma.<\/span><\/p>\n <\/p>\n
Description of Working Group:<\/em><\/h4>\nThe European Retinoblastoma Imaging Collaboration was founded in 2009 and since then this international group of radiologists has met twice a year in Amsterdam with the aim of increasing the quality and diagnostic value of MRI in retinoblastoma through multicenter research.<\/p>\n
<\/p>\n
Objectives of Working Group:\u00a0<\/em><\/h4>\n\n- \n
\n- To harmonize high-quality MR imaging through development of guidelines for retinoblastoma imaging.<\/li>\n
- To improve disease staging by enhancing diagnostic accuracy for pretreatment detection of high-risk features.<\/li>\n
- To identify the influence of genetic driver mutations and other chromosomal abnormalities on the retinoblastoma radiophenotype.<\/li>\n<\/ol>\n<\/li>\n<\/ol>\n
[\/vc_column_text][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner][vc_separator type=”normal”][vc_column_text]<\/p>\n
Guidelines<\/em><\/h4>\nOn behalf of the ERIC and EURbG we propose an updated MR protocol and a standardized reporting system<\/strong> based on the key points essential for managing patients with retinoblastoma by ophthalmologists and pediatric oncologists. Following the guidelines leads to state-of-the-art imaging in \u00a0retinoblastoma and can improve diagnostic yield and understanding of clinically significant imaging features of retinoblastoma.<\/span><\/p>\n <\/p>\n
- \n
- \n
- \n
- To harmonize high-quality MR imaging through development of guidelines for retinoblastoma imaging.<\/li>\n
- To improve disease staging by enhancing diagnostic accuracy for pretreatment detection of high-risk features.<\/li>\n
- To identify the influence of genetic driver mutations and other chromosomal abnormalities on the retinoblastoma radiophenotype.<\/li>\n<\/ol>\n<\/li>\n<\/ol>\n
[\/vc_column_text][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner][vc_separator type=”normal”][vc_column_text]<\/p>\n
Guidelines<\/em><\/h4>\n
On behalf of the ERIC and EURbG we propose an updated MR protocol and a standardized reporting system<\/strong> based on the key points essential for managing patients with retinoblastoma by ophthalmologists and pediatric oncologists. Following the guidelines leads to state-of-the-art imaging in \u00a0retinoblastoma and can improve diagnostic yield and understanding of clinically significant imaging features of retinoblastoma.<\/span><\/p>\n
<\/p>\n